Open access · CC-BY
via OpenAlex
PINK1‑regulated mitophagy dysfunction in the pathogenesis of Parkinson's disease (Review)
Han-Liang Dan, Shu-Er Liu, Yu-Jie Zhao, Zi-Fan Zhu, Hao-gang LI, Yi-Xiang Huang, Mei Chen, Yi-Hui Zhang, Hui-Xin Ai, Xiaohui Huang, Hai-Yun Zhao, Zheng Liu, Pan Zou, Maslinda Binti Musa
Molecular Medicine Reports · 2026
Abstract
Parkinson's disease (PD) is the second most common neurodegenerative disorder, characterized by the progressive loss of dopaminergic neurons in the substantia nigra and the accumulation of misfolded α‑synuclein forming Lewy bodies. Emerging evidence highlights mitochondrial dysfunction(definition) as an important and early event in PD pathogenesis. Among the key regulators of mitochondrial quality control, PTEN‑induced kinase 1 (PINK1) plays a pivotal role by initiating mitophagy, the selective clearance of damaged mitochondria. Under physiological conditions, PINK1 is rapidly degraded, whereas mitochondrial depolarization stabilizes PINK1 on the outer mitochondrial membrane, where it recruits and activates Parkin, an E3 ubiquitin ligase, to promote mitophagy. Loss‑of‑function mutations in PINK1 also disrupt this process, leading to the accumulation of dysfunctional mitochondria, oxidative stress, abnormal calcium homeostasis and neuronal apoptosis. Furthermore, PINK1 deficiency has been shown to exacerbate α‑synuclein aggregation, impair synaptic transmission and activate neuroinflammatory pathways, collectively accelerating dopaminergic neurodegeneration. Therapeutic strategies aimed at restoring or enhancing PINK1‑mediated mitophagy through pharmacological activation, gene delivery or modulation of parallel pathways‑represent a promising avenue for PD intervention. Continued elucidation of the molecular functions of PINK1 will provide critical insights into mitochondrial homeostasis and novel therapeutic targets for PD.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.3892/mmr.2026.14069
- Canonical
- link ↗
- Fetched
- 2026-11-15 MST
Cite this
APA
Dan, H., Liu, S., Zhao, Y., Zhu, Z., LI, H., Huang, Y., Chen, M., Zhang, Y., Ai, H., Huang, X., Zhao, H., Liu, Z., Zou, P., & Musa, M.B. (2026). PINK1‑regulated mitophagy dysfunction in the pathogenesis of Parkinson's disease (Review). <em>Molecular Medicine Reports</em>. https://doi.org/10.3892/mmr.2026.14069
Vancouver
Dan H, Liu S, Zhao Y, Zhu Z, LI H, Huang Y, et al. PINK1‑regulated mitophagy dysfunction in the pathogenesis of Parkinson's disease (Review). Molecular Medicine Reports. 2026. doi:10.3892/mmr.2026.14069.
BibTeX
@article{hanliang2026PINKre,
title = {PINK1‑regulated mitophagy dysfunction in the pathogenesis of Parkinson's disease (Review)},
author = {Han-Liang Dan and Shu-Er Liu and Yu-Jie Zhao and Zi-Fan Zhu and Hao-gang LI and Yi-Xiang Huang and Mei Chen and Yi-Hui Zhang and Hui-Xin Ai and Xiaohui Huang and Hai-Yun Zhao and Zheng Liu and Pan Zou and Maslinda Binti Musa},
journal = {Molecular Medicine Reports},
year = {2026},
doi = {10.3892/mmr.2026.14069},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Oxidative Medicine and Cellular Longevity 2017
Open access · CC-BY
Mitophagy Transcriptome: Mechanistic Insights into Polyphenol‐Mediated Mitophagy
Molecular Neurodegeneration 2020
Open access · CC-BY
PINK1 and Parkin mitochondrial quality control: a source of regional vulnerability in Parkinson’s disease
Scientific Reports 2019
Open access · CC-BY
Pomegranate activates TFEB to promote autophagy-lysosomal fitness and mitophagy
Journal of Clinical Investigation 2026
Open access · CC-BY
Mitophagy in neuronal health and disease: from mechanisms to neurodegeneration
The Journal of clinical investigation 2026
Open access · OA
Mitophagy in neuronal health and disease: from mechanisms to neurodegeneration.
Genes 2017
Open access · CC-BY